45 related articles for article (PubMed ID: 3708877)
21. PRKAR1A-negative familial Cushing's syndrome: two case reports.
Lim LL; Kitan N; Paramasivam SS; Ratnasingam J; Ibrahim L; Chan SP; Tan AT; Vethakkan SR
J Med Case Rep; 2015 Dec; 9():277. PubMed ID: 26619967
[TBL] [Abstract][Full Text] [Related]
22. Primary pigmented nodular adrenocortical dysplasia.
Köhler G; Anding K; Böhm N
Pathol Res Pract; 1998; 194(3):201-4. PubMed ID: 9587940
[TBL] [Abstract][Full Text] [Related]
23. Familial Cushing's syndrome due to nodular adrenocortical dysplasia. A putative receptor-antibody disease?
Teding van Berkhout F; Croughs RJ; Kater L; Schuurman HJ; Gmelig Meyling FJ; Kooyman CD; van der Gaag RD; Jolink D; Drexhage HA
Clin Endocrinol (Oxf); 1986 Mar; 24(3):299-310. PubMed ID: 3708877
[TBL] [Abstract][Full Text] [Related]
24. Cushing's syndrome due to primary pigmented nodular adrenocortical disease--a case report reviews of the literature.
Choi KM; Seu JH; Kim YH; Lee EJ; Kim SJ; Baik SH; Choi DS
Korean J Intern Med; 1995 Jan; 10(1):68-72. PubMed ID: 7626560
[TBL] [Abstract][Full Text] [Related]
25. Bilateral adrenal Cushing's syndrome: macronodular adrenal hyperplasia and primary pigmented nodular adrenocortical disease.
Lacroix A; Bourdeau I
Endocrinol Metab Clin North Am; 2005 Jun; 34(2):441-58, x. PubMed ID: 15850852
[TBL] [Abstract][Full Text] [Related]
26. Adrenocorticotropic hormone-independent Cushing's syndrome.
Bourdeau I; Lampron A; Costa MH; Tadjine M; Lacroix A
Curr Opin Endocrinol Diabetes Obes; 2007 Jun; 14(3):219-25. PubMed ID: 17940443
[TBL] [Abstract][Full Text] [Related]
27. Primary pigmented nodular adrenocortical disease and Cushing's syndrome.
Horvath A; Stratakis C
Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1238-44. PubMed ID: 18209861
[TBL] [Abstract][Full Text] [Related]
28. Role of unilateral adrenalectomy in bilateral adrenal hyperplasias with Cushing's syndrome.
Meloche-Dumas L; Mercier F; Lacroix A
Best Pract Res Clin Endocrinol Metab; 2021 Mar; 35(2):101486. PubMed ID: 33637447
[TBL] [Abstract][Full Text] [Related]
29. Primary pigmented nodular adrenocortical disease: literature review and case report of a 6-year-old boy.
Katanić D; Kafka D; Živojinov M; Vlaški J; Budakov Z; Knežević Pogančev M; Vorgučin I; Ćuk T
J Pediatr Endocrinol Metab; 2017 May; 30(5):603-609. PubMed ID: 28391254
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological correlates of adrenal Cushing's syndrome.
Duan K; Gomez Hernandez K; Mete O
J Clin Pathol; 2015 Mar; 68(3):175-86. PubMed ID: 25425660
[TBL] [Abstract][Full Text] [Related]
31. Primary pigmented nodular adrenocortical disease. A light and electron microscopic study of eight cases.
Travis WD; Tsokos M; Doppman JL; Nieman L; Chrousos GP; Cutler GB; Loriaux DL; Norton JA
Am J Surg Pathol; 1989 Nov; 13(11):921-30. PubMed ID: 2679153
[TBL] [Abstract][Full Text] [Related]
32. PRKAR1A mutations in primary pigmented nodular adrenocortical disease.
Cazabat L; Ragazzon B; Groussin L; Bertherat J
Pituitary; 2006; 9(3):211-9. PubMed ID: 17036196
[TBL] [Abstract][Full Text] [Related]
33. ACTH-independent bilateral macronodular adrenocortical hyperplasia caused Cushing's syndrome.
Miyajima A; Nakashima J; Tachibana M; Baba S; Nakamura K; Murai M
Urol Int; 1997; 58(4):259-61. PubMed ID: 9253133
[TBL] [Abstract][Full Text] [Related]
34. Primary adrenocortical nodular dysplasia, a distinct subtype of Cushing's syndrome. Case report and review of the literature.
Larsen JL; Cathey WJ; Odell WD
Am J Med; 1986 May; 80(5):976-84. PubMed ID: 3010718
[TBL] [Abstract][Full Text] [Related]
35. [Cushing's syndrome: special issues].
Goñi Iriarte MJ
Endocrinol Nutr; 2009 May; 56(5):251-61. PubMed ID: 19627746
[TBL] [Abstract][Full Text] [Related]
36. [Clinical and preclinical aspects of adrenal Cushing syndrome].
Ambrosi B; Re T; Passini E; Peverelli S; Sartorio A; Colombo P
Minerva Endocrinol; 1995 Mar; 20(1):39-47. PubMed ID: 7651281
[TBL] [Abstract][Full Text] [Related]
37. Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias.
Stratakis CA; Boikos SA
Nat Clin Pract Endocrinol Metab; 2007 Nov; 3(11):748-57. PubMed ID: 17955016
[TBL] [Abstract][Full Text] [Related]
38. Detection of new potentially pathogenic mutations in two patients with primary pigmented nodular adrenocortical disease (PPNAD) - case reports with literature review.
Pasternak-Pietrzak K; Stratakis CA; Moszczyńska E; Lecka-Ambroziak A; Staniszewski M; Wątrobińska U; Lyssikatos C; Prokop-Piotrkowska M; Grajkowska W; Pronicki M; Szalecki M
Endokrynol Pol; 2018; 69(6):675-681. PubMed ID: 30259502
[TBL] [Abstract][Full Text] [Related]
39. Adrenocorticotropic hormone-independent bilateral adrenocortical macronodular hyperplasia as a distinct subtype of Cushing's syndrome. Enzyme histochemical and ultrastructural study of four cases with a review of the literature.
Aiba M; Hirayama A; Iri H; Ito Y; Fujimoto Y; Mabuchi G; Murai M; Tazaki H; Maruyama H; Saruta T
Am J Clin Pathol; 1991 Sep; 96(3):334-40. PubMed ID: 1652202
[TBL] [Abstract][Full Text] [Related]
40. Primary pigmented nodular adrenocortical disease associated with Carney complex: case report and literature review.
Gonçalves FT; Feibelmann TC; Mendes CM; Fernandes ML; Miranda GH; Gouvêa AP; Jorge PT
Sao Paulo Med J; 2006 Nov; 124(6):336-9. PubMed ID: 17322955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
